Xu R, Fu J, Hu Y, Yang X, et al. Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering. Diabetes 2022 May 20. pii: 146983. doi: 10.2337/db21-0898.
PMID: 35594380